BCBT-PC: Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care

Sponsor
San Diego State University (Other)
Overall Status
Completed
CT.gov ID
NCT01147614
Collaborator
University of Pittsburgh (Other), Kaiser Permanente (Other), National Institute of Mental Health (NIMH) (NIH)
185
2
2
67
92.5
1.4

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether a brief (12 week) psychological treatment program, based in primary care, can help youths struggling with anxiety and/or depression. This brief cognitive behavioral therapy program will be compared to enhanced referral to specialty mental health care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Brief Cognitive Behavioral Therapy (BCBT)
  • Behavioral: Specialty mental health care referral (SMHC)
N/A

Detailed Description

Mood and anxiety disorders in childhood and adolescence are disabling, distressing, and prevalent and produce added costs to health systems. This two-site randomized controlled trial will test the effects of a brief cognitive behavioral therapy (BCBT) protocol (8-12 sessions) in a large sample (N=210) of children and adolescents (age 8-16) presenting with anxiety and/or depression in primary care. Clinical and cost-effectiveness of BCBT will be compared to a plausible public health alternative - enhanced referral to specialty mental health care (SMHC). This investigation is noteworthy in adopting a deployment-focused model and testing this intervention early in its development within a real world context (primary care) and against a plausible public health comparison condition (SMHC) relevant for future treatment dissemination.

Study Design

Study Type:
Interventional
Actual Enrollment :
185 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Brief CBT for Pediatric Anxiety and Depression in Primary Care
Study Start Date :
Sep 1, 2010
Actual Primary Completion Date :
Apr 1, 2016
Actual Study Completion Date :
Apr 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: specialty mental health care referral

Behavioral: Specialty mental health care referral (SMHC)
SMHC: specialty mental health care referrals provided
Other Names:
  • SMHC
  • Experimental: Brief Cognitive Behavioral Therapy

    Behavioral: Brief Cognitive Behavioral Therapy (BCBT)
    BCBT: 8-12 sessions over 16 weeks of cognitive-behavioral therapy administered by Master's-level clinicians in primary care setting
    Other Names:
  • BCBT
  • Outcome Measures

    Primary Outcome Measures

    1. Clinical Global Impression [measured at baseline (week 0)]

    2. Clinical Global Impression [measured at post-treatment (week 16)]

    3. Clinical Global Impression [measured at 8 month follow-up (week 32)]

    Secondary Outcome Measures

    1. Pediatric Anxiety Rating Scale [measured at baseline (week 0)]

    2. Children's Depression Rating Scale - Revised [measured at baseline (week 0)]

    3. Health Utilities Index [measured at baseline (week 0)]

      This measure will aid in cost-effectiveness analyses.

    4. Pediatric Anxiety Rating Scale [measured at post-treatment (week 16)]

    5. Pediatric Anxiety Rating Scale [measured at 8 month follow-up (week 32)]

    6. Children's Depression Rating Scale - Revised [measured at post-treatment (week 16)]

    7. Children's Depression Rating Scale - Revised [measured at 8 month follow-up (week 32)]

    8. Health Utilities Index [measured at post-treatment (week 16)]

      This measure will aid in cost-effectiveness analyses.

    9. Health Utilities Index [measured at 8 month follow-up (week 32)]

      This measure will aid in cost-effectiveness analyses.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Years to 16 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • meet full or probable diagnostic criteria for Separation Anxiety Disorder, Generalized Anxiety Disorder, Social Phobia, Major Depression, Dysthymic Disorder, or Minor Depression

    • age 8.0 to 16.9

    • live with legal, consenting guardian for at least 6 months

    Exclusion Criteria:
    • youths requiring alternate intervention (e.g., youths with bipolar disorder, psychosis, active suicidal ideation with plan, PTSD, substance dependence, current physical or sexual abuse, or mental retardation

    • suffer from serious or unstable physical illness (e.g., uncontrolled diabetes)

    • currently in active, alternate intervention for anxiety or depression (e.g., antidepressant use)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 San Diego State University San Diego California United States 92120
    2 Western Psychiatric Institute and Clinics Pittsburgh Pennsylvania United States 15213

    Sponsors and Collaborators

    • San Diego State University
    • University of Pittsburgh
    • Kaiser Permanente
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: V. Robin Weersing, Ph.D., San Diego State University
    • Principal Investigator: David A Brent, M.D., Western Psychiatric Institute and Clinics

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    V. Robin Weersing, Associate Professor, San Diego State University
    ClinicalTrials.gov Identifier:
    NCT01147614
    Other Study ID Numbers:
    • 7887933
    • 5R01MH084935
    First Posted:
    Jun 22, 2010
    Last Update Posted:
    Apr 14, 2016
    Last Verified:
    Apr 1, 2016
    Keywords provided by V. Robin Weersing, Associate Professor, San Diego State University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 14, 2016